REALM THERAPEUTICS PLC 
By MALVERN, PENNSYLVANIA, October 19, 2011 - PuriCore(LSE: PURI), the water-based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announced that it has been named to the Deloitte Philadelphia Fast 50 for the fourth year in a row and again to the Deloitte Technology Fast 500™ ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. PuriCore grew 155 percent during this period.
"We are honored to rank once again as one of the fastest
growing companies in Philadelphia as well as nationally,"
said Greg Bosch, CEO of PuriCore. "PuriCore's
industry-leading products naturally and safely protect
millions of people each day from the increasing spread of
infectious pathogens including MRSA, e.Coli, and C.difficile.
We are proud of our exceptional technology, products and
services as well as the outstanding
PuriCore team that develops and delivers these solutions to
customers."
"PuriCore, like all 2011 Technology Fast 500 companies, has
excelled in fostering innovation and channeling it into
spectacular growth -- against the backdrop of one of the most
a challenging economies in history," said Eric Openshaw, vice
chairman and U.S. technology, media and telecommunications
leader, Deloitte LLP. "Deloitte recognizes PuriCore for
its remarkable accomplishment."
"We are pleased to honor PuriCore as a 2011 Technology Fast
500 company," said Mark Jensen, managing partner, technology
and venture capital services, Deloitte & Touche LLP. "As one
of the fastest growing tech companies in North America,
PuriCore has demonstrated excellence in technological
innovation, entrepreneurship and rapid growth."
Sage Strategic Marketing Jennifer Guinan Jennifer@sagestrat.com
610.410.8111
About PuriCorePuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore's patented, proprietary technology mimics the human body's production of the natural antimicrobial hypochlorous acid, offering a safe and non-hazardous approach to disinfection and sanitisation. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. Hypochlorous acid is proven to be safe, environmentally friendly, and fast acting against a broad
1
range of infectious pathogens, including major public health
threats of C.difficile, E.coli, HIV, Human and Animal
Influenza (including H1N1 and H5N1), Legionella, MRSA,
M.tuberculosis, Norovirus, and Salmonella. PuriCore is
headquartered in Malvern, Pennsylvania, with operations in
Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit
our website at www.puricore.com, which does
not form part of this press release.
2
